Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 65.25
-0.33 (-0.50%)
At close: Nov 14, 2025
SHA:688192 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -867.44 | -845.96 | -1,108 | -736 | -669.88 | -586.61 | Upgrade |
Depreciation & Amortization | 64.21 | 64.21 | 65.58 | 58.43 | 53.72 | 29.82 | Upgrade |
Other Amortization | 12.81 | 12.81 | 7.1 | 4.64 | 1.86 | 0.74 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 0.01 | -0.02 | - | -198.82 | Upgrade |
Loss (Gain) From Sale of Investments | -14.45 | -14.45 | -22.52 | -42.16 | -2.37 | -2.65 | Upgrade |
Stock-Based Compensation | - | - | - | 27.89 | 61.97 | 400.52 | Upgrade |
Provision & Write-off of Bad Debts | -0.12 | -0.12 | 0.4 | -0.02 | 0 | -0.01 | Upgrade |
Other Operating Activities | -7.76 | -68.49 | 6.6 | -5.17 | 9.4 | 17.68 | Upgrade |
Change in Accounts Receivable | 23.7 | 23.7 | -57.22 | -0.72 | -17.93 | -1.14 | Upgrade |
Change in Inventory | -20.64 | -20.64 | -18.4 | -5.07 | - | - | Upgrade |
Change in Accounts Payable | 65.6 | 65.6 | -38.33 | 94.83 | 70.93 | -69.54 | Upgrade |
Change in Other Net Operating Assets | 132.82 | 132.82 | 196.61 | - | - | - | Upgrade |
Operating Cash Flow | -611.27 | -650.53 | -967.88 | -603.37 | -492.28 | -410.01 | Upgrade |
Capital Expenditures | -193.44 | -137.58 | -32.13 | -73.78 | -8.98 | -211.73 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | - | 0 | 0 | - | - | Upgrade |
Investment in Securities | -210.06 | 99.5 | 643.32 | 458.34 | -1,620 | -78 | Upgrade |
Other Investing Activities | - | - | - | - | 1.68 | 204.69 | Upgrade |
Investing Cash Flow | -403.49 | -38.07 | 611.19 | 384.56 | -1,627 | -85.04 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 19.54 | - | Upgrade |
Long-Term Debt Issued | - | 963.36 | 338.23 | - | - | - | Upgrade |
Total Debt Issued | 817.1 | 963.36 | 338.23 | - | 19.54 | - | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -19.54 | - | Upgrade |
Long-Term Debt Repaid | - | -233.51 | -26.32 | -22.14 | -18.01 | - | Upgrade |
Total Debt Repaid | -671.63 | -233.51 | -26.32 | -22.14 | -37.55 | - | Upgrade |
Net Debt Issued (Repaid) | 145.47 | 729.85 | 311.91 | -22.14 | -18.01 | - | Upgrade |
Issuance of Common Stock | 1,935 | 158.27 | 1.25 | 3.75 | 2,022 | 814.6 | Upgrade |
Common Dividends Paid | -33.78 | -20.55 | -3.38 | - | - | - | Upgrade |
Other Financing Activities | -145.2 | -0.55 | -1.53 | -14.88 | -22.45 | - | Upgrade |
Financing Cash Flow | 1,901 | 867.01 | 308.25 | -33.26 | 1,981 | 814.6 | Upgrade |
Foreign Exchange Rate Adjustments | -2.43 | -2.45 | 0.97 | 9.52 | -6.33 | -17.4 | Upgrade |
Net Cash Flow | 883.93 | 175.96 | -47.47 | -242.56 | -144.78 | 302.14 | Upgrade |
Free Cash Flow | -804.72 | -788.1 | -1,000 | -677.15 | -501.26 | -621.75 | Upgrade |
Free Cash Flow Margin | -132.41% | -218.98% | -1095.44% | - | -4873.51% | -2239.65% | Upgrade |
Free Cash Flow Per Share | -1.85 | -1.90 | -2.46 | -1.67 | -1.39 | -1.73 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.05 | - | Upgrade |
Cash Income Tax Paid | 27.69 | 20.7 | -5.18 | -68.69 | -25.17 | -21.93 | Upgrade |
Levered Free Cash Flow | -450.15 | -423.64 | -596.9 | -468.46 | -234.15 | -332.66 | Upgrade |
Unlevered Free Cash Flow | -430.83 | -409.42 | -592.17 | -465.75 | -232.23 | -332.66 | Upgrade |
Change in Working Capital | 201.47 | 201.47 | 82.66 | 89.05 | 53.01 | -70.68 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.